Literature DB >> 27001279

Lactobacillus sakei OK67 ameliorates high-fat diet-induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression.

Su-Min Lim1, Jin-Ju Jeong2, Kyung Hee Woo3, Myung Joo Han4, Dong-Hyun Kim5.   

Abstract

A high-fat diet (HFD) induces obesity and the associated increases in blood glucose and inflammation through changes in gut microbiota, endotoxemia, and increased gut permeability. To counteract this, researchers have suggested that the use of probiotics that suppress production of proinflammatory lipopolysaccharide (LPS). Here, we tested whether Lactobacillus sakei OK67, which inhibits gut microbiota LPS production selected from among the lactic acid bacteria isolated from kimchi, exerted antihypoglycemic or anti-inflammatory effects in HFD-fed mice. Mice were randomly divided into 2 groups and fed an HFD or a low-fat diet for 4 weeks. These groups were further subdivided; 1 subgroup was treated with L sakei OK67 and fed the experimental diet for 4.5 weeks, whereas the other subgroup was fed the experimental diet alone. L sakei OK67 treatment lowered HFD-elevated LPS levels in blood and colonic fluid and significantly decreased HFD-elevated fasting blood glucose levels and the area under the curve in an oral glucose tolerance test. L sakei OK67 treatment inhibited HFD-induced body and epididymal fat weight gains, suppressed HFD-induced tumor necrosis factor-α and interleukin-1β expression and nuclear factor-κB activation in the colon, and significantly increased HFD-suppressed interleukin-10 and tight junction protein expression in the colon. Oral administration of L sakei OK67 significantly downregulated HFD-induced expression of peroxisome proliferator-activated receptor γ, fatty acid synthase, and tumor necrosis factor-α in adipose tissue. In addition, L sakei OK67 treatment strongly inhibited nuclear factor-κB activation in LPS-stimulated peritoneal macrophages. We report that L sakei OK67 ameliorates HFD-induced hyperglycemia and obesity by reducing inflammation and increasing the expression of colon tight junction proteins in mice.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colitis-associated inflammation; Gut microbiota lipopolysaccharide; Hyperglycemia; Lactobacillus sakei; Obesity

Mesh:

Substances:

Year:  2015        PMID: 27001279     DOI: 10.1016/j.nutres.2015.12.001

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  38 in total

Review 1.  Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.

Authors:  Li Wen; Andrew Duffy
Journal:  J Nutr       Date:  2017-06-14       Impact factor: 4.798

Review 2.  Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung.

Authors:  Mark A Underwood; Satyan Lakshminrusimha; Robin H Steinhorn; Stephen Wedgwood
Journal:  J Perinatol       Date:  2020-10-14       Impact factor: 2.521

3.  Distinct Effects of Milk-Derived and Fermented Dairy Protein on Gut Microbiota and Cardiometabolic Markers in Diet-Induced Obese Mice.

Authors:  Laís Rossi Perazza; Noëmie Daniel; Marie-Julie Dubois; Geneviève Pilon; Thibault Vincent Varin; Mylène Blais; José Luis Martinez Gonzales; Michaël Bouchard; Claude Asselin; Martin Lessard; Yves Pouliot; Denis Roy; André Marette
Journal:  J Nutr       Date:  2020-10-12       Impact factor: 4.798

Review 4.  Some current applications, limitations and future perspectives of lactic acid bacteria as probiotics.

Authors:  Smith Etareri Evivie; Gui-Cheng Huo; John Oamen Igene; Xin Bian
Journal:  Food Nutr Res       Date:  2017-05-03       Impact factor: 3.894

5.  Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats.

Authors:  Wannipa Tunapong; Nattayaporn Apaijai; Sakawdaurn Yasom; Pongpan Tanajak; Keerati Wanchai; Titikorn Chunchai; Sasiwan Kerdphoo; Sathima Eaimworawuthikul; Parameth Thiennimitr; Anchalee Pongchaidecha; Anusorn Lungkaphin; Wasana Pratchayasakul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Eur J Nutr       Date:  2017-06-12       Impact factor: 5.614

6.  Isolation of acid tolerant lactic acid bacteria and evaluation of α-glucosidase inhibitory activity.

Authors:  Se Young Kwun; Young Woo Bae; Jeong Ah Yoon; Eun Hee Park; Myoung Dong Kim
Journal:  Food Sci Biotechnol       Date:  2020-06-02       Impact factor: 2.391

7.  Elemental iron modifies the redox environment of the gastrointestinal tract: A novel therapeutic target and test for metabolic syndrome.

Authors:  Charlene B Van Buiten; Guojun Wu; Yan Y Lam; Liping Zhao; Ilya Raskin
Journal:  Free Radic Biol Med       Date:  2021-04-05       Impact factor: 7.376

8.  Lactobacillus plantarum ATG-K2 and ATG-K6 Ameliorates High-Fat with High-Fructose Induced Intestinal Inflammation.

Authors:  Miey Park; Eun-Jung Park; So-Hyeun Kim; Hae-Jeung Lee
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

9.  Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity.

Authors:  Luca Antonioli; Valentina Caputi; Matteo Fornai; Carolina Pellegrini; Daniela Gentile; Maria Cecilia Giron; Genny Orso; Nunzia Bernardini; Cristina Segnani; Chiara Ippolito; Balázs Csóka; György Haskó; Zoltán H Németh; Carmelo Scarpignato; Corrado Blandizzi; Rocchina Colucci
Journal:  Int J Obes (Lond)       Date:  2018-08-06       Impact factor: 5.095

10.  The metabolic effect of fructose on normal rats in a mild dose with glucose and saccharose as control.

Authors:  Ge Song; Wentao Qi; Yong Wang; Shaojie Pang; Yong Li
Journal:  Food Nutr Res       Date:  2021-05-18       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.